The emerging role of academia in commercializing innovation

Nature Biotechnology

Volumn 22, Issue 1, 2004, Pages 21-24

  Mehta, Shreefal ^a  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; COMMERCIAL PHENOMENA; INTERNET; NOTE; PRIORITY JOURNAL; UNITED STATES; UNIVERSITY;

ACADEMIES AND INSTITUTES; BIOTECHNOLOGY; CONFLICT OF INTEREST; DIFFUSION OF INNOVATION; INDUSTRY; INVESTMENTS; RESEARCH; RESEARCH SUPPORT;

EID: 0347986656     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0104-21     Document Type: Note

References (30)

1. http://www.autm.net/
2. Casper, S. & Kettler, H. Industry Innovation 8, 5-30 (April 2001).
3. Triendl, R. Res. Technol. Management 42, 5-7 (Mar/Apr 1999).
4. Feldman, M. et al. Management Sci. 48, 105-121 (2002).
5. Press, E. & Washburn, J. Atl. Mon. 285, 39-54 (March 2000).
6. Munro, N. Natl. J. 580-585 (22 February, 2003).
7. Cohen, W.M., Florida, R., Randazzese, L. & Walsh, J. in Challenges to Research Universities (ed. R. Noll) 171199 (Brookings Institution Press, Washington, DC, 1998).
8. Pressman, L. (ed.). AUTM Licensing Survey: FY 2001 Survey Summary (AUTM, Northbrook, II, USA, 2003) (http://www.autm.net/surveys/01/01summarypublicversion.pdf).
9. http://www.nibib.nih.gov/
10. Pulley, J. Chronicle Higher Edu. 49, A23 (January 24, 2003).
11. Basinger, J. Chronicle Higher Edu. 49, A32 (December 13, 2002).
12. Barker, E. Inc. Magazine, p. 66 (November, 2002).
13. Tornatzky, L.G., Waugaman, P.G. & Gray, D.O. Innovation University; New University Roles In A Knowledge Economy (Southern Technology Council and Southern Growth Policies Board, Research Triangle Park, NC, 2002).
14. DiMasi, J.A., Hansen, R.W. & Grabowski, H.G. J. Health Economics 22, 151-185 (2003).
15. The Pharmaceutical Research and Manufacturers of America. New Drug Approvals in 2001 (PhRMA, Washington, DC, USA) p. 17 (January 2002) (http://www.phrma.org/newmedicines/resources/2002-01-25.46.pdf).
16. Guyer, R.L. People doing science (NIH, Bethseda, MD, USA) (http://www4.od.nih.gov/officeofbudget/FY04pub/MechanismTotal.PDF)
17. Department of Health and Human Services. NIH Response to the Conference Report Request for a Plan to Ensure Taxpayers' Interests are Protected (NIH, Bethseda, MD, USA) (July 2001) (http://www.nih. gov/news/070101wyden.htm).
18. Pollack, A. UCSD getting more involved in drug trials. SignOnSanDiego.com, 31 July 2003 (http://www.signonsandiego.com/news/business/biotech/20030731-9999_1b31biotech. html).
19. Gwynne, P. Drug Disc. Dev., p. 81 (October 1, 2002).
20. Kalorama Information. Outsourcing in Drug Discovery (Kalorama Information, New York, NY, USA, 2003).
21. Waltham, M. M. (ed.). Parexel's Pharmaceutical R&D Statistical Sourcebook. p. 25 (Parexel International Corporation, Waltham, MA, USA, 2001).
22. GlaxoSmithKline. GlaxoSmithKline unveils strategy for growth (GSK, Brentford, UK) (February 22, 2001) (http://www.gsk.com/press_archive/press 02222001.htm).
23. Dyer, G. Financial Times, p. 19, London edn, (January 25, 2002).
24. Baltimore, D. et al. US Patent 6,410,516 (issued June 25, 2002).
25. Young, D.A. et al. US Patent 6,048,850 (issued April 11, 2000).
26. Shulman, S. MIT Technol. Rev. 106, 75 (2003).
27. Russo, E. The Scientist, 14, 8 (2000).
28. Rai, A.K. & Eisenberg, R.S. Law Contemp. Problems 66,289 (2003).
29. Rai, A.K. & Eisenberg, R.S. Am. Sci. 91, 52 (2003).
30. Agres, T. The Scientist 17, 58-59 (2003).